Skip to content Skip to footer

Our Investors

CTI Life Sciences

Based in Montreal, CTI Life Sciences Fund L.P. was created in 2006. The firm makes venture capital investments mostly in innovative high quality biotech companies at the pre-clinical and clinical development stages, in North America, and primarily in Canada. Since its second mandate in 2014, CTI Life Sciences Fund manages $245 million of assets.

Admare BioInnovations

With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To realize this potential, adMare uses its scientific and commercial expertise, specialized R&D infrastructure, and investment capital to build investable companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term.

Domain Therapeutics

Domain Therapeutics, a biopharmaceutical company operating in France and Canada, is dedicated to the discovery and development of new drug candidates targeting G Protein Coupled Receptors (GPCRs), one of the most important classes of drug targets. Over the last decade, the company has created a proprietary pipeline in immuno-oncology, neurology and rare diseases and is now focusing on delivering and developing high-value drug candidates to tackle GPCR-mediated immunosuppression in immune-oncology. The company has signed multiple partnering agreements with pharmaceutical companies.

7171 Frederick-Banting
Saint-Laurent, Québec 
H4S 1Z9,  Canada

Finding hope by expanding the frontiers of therapy

Find Therapeutics © 2022. All Rights Reserved.